Account

Sign in to access your account and subscription

Agfa Corp. v. Creo Prods. Inc.: Did the Court's Decision Change a Patentee's Right to a Jury Trial on the Issue of Inequitable Conduct?

In <i>Agfa Corp. v. Creo Prods. Inc.</i>, 451 F.3d 1366 (Fed. Cir. 2006), a non-unanimous panel of the Court of Appeals for the Federal Circuit ('CAFC') issued an opinion affirming a district court's decision to conduct a bench trial on the defense of inequitable conduct, in spite of the patentee's request for a jury trial, prior to holding a jury trial on patent infringement, patent invalidity, and all other issues in the case. The dissenting member of the panel disagreed with the majority's decision that the patentee in this case did not have a right to a jury trial on the issue of inequitable conduct and suggested that the CAFC majority opinion in <i>Agfa</i> changed precedent established in a prior decision. In deciding <i>Agfa</i>, the majority analyzed the CAFC's decision in <i>Gardco Mfg. v. Herst Lighting Co.</i>, 820 F.2d 1209 (Fed. Cir. 1987) and determined that it applied to the case in <i>Agfa</i>. The majority also distinguished the CAFC decision in <i>In re Lockwood</i>, 50 F.3d 966 (Fed. Cir. 1995), <i>vacated</i>, 515 U.S. 1182 (1995), as inapplicable to the equitable issue in question in <i>Agfa</i>. Conversely, the dissenting panel member argued that the CAFC's decision in <i>Lockwood</i> was indeed applicable to the issues in Agfa. This article reviews the above cases with the goal of determining if the CAFC decision in <i>Agfa</i> is indeed a departure from its previous jurisprudence concerning a patentee's right to a jury trial on the issue of equitable conduct.

30 minute read September 28, 2006 at 03:45 PM
By
Dion Messer
Agfa Corp. v. Creo Prods. Inc.: Did the Court's Decision Change a Patentee's Right to a Jury Trial on the Issue of Inequitable Conduct?

In Agfa Corp. v. Creo Prods. Inc., 451 F.3d 1366 (Fed.

This premium content is locked for LawJournalNewsletters subscribers only

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

Already have an account? Sign In Now

For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.

NOT FOR REPRINT

© 2026 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Continue Reading

The combination of increasing operating costs and uncertain government reimbursement funding continues to place health care providers under financial pressure, and in many cases, financial distress. Given the importance of Medicare/Medicaid funding of claims under provider agreements with the federal government, how courts interpret and apply the interplay between the Bankruptcy Code and Medicare Program Act determines the disposition of hundreds of millions of dollars of claims for reimbursement that support the health care system.

April 30, 2026

As AI becomes embedded in everyday business and legal operations, organizations are confronting a new expectation: simply disclosing AI use is no longer enough. A critical shift is taking place in the legal industry: transparency is no longer just about disclosure; it’s about comprehension.

April 30, 2026